Related Experiment Video
Updated: Jul 7, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Persistent erythema multiforme treated with thalidomide
Chia-Wei Chen1, Tsen-Fang Tsai, Yu-Fu Chen
1Department of Dermatology, Show Chwan Memorial Hospital, Taiwan, Republic of China.
Abstract:
Erythema multiforme is a common self-limited disorder that predominantly affects younger individuals. It is characterized by typical iris or target lesions on the skin and mucous membranes. Three clinical subgroups of erythema multiforme have been identified: classical erythema multiforme, recurrent erythema multiforme, and persistent erythema multiforme. By definition, persistent erythema multiforme is characterized by the occurrence of continuous typical and atypical lesions without interruption. We report a 15-year-old boy who developed persistent erythema multiforme for 6 months and responded to treatment with thalidomide.
Related Concept Videos
Rocky Mountain Spotted Fever
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Graves' Disease I: Introduction
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Teratogenicity
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...